NFKB1 and cervical carcinoma: However, there were no significant changes of PKA, ERK1/2, EGFR or PI3K/AKT.52 Thus further investigation of TLR4 and the NF-κB pathway and their mechanism of action will help provide new ideas in developing therapeutic strategies to treat cervical cancer.